XBiotech: Rises on accelerating antibody therapy for COVID-19

XBiotech

01/05/2020 15:12

** Shares of drug developer  XBIT.O  rise 1.3% to $16.03 
** Co says human immune donors have been identified that can
support the development of COVID-19 human antibody therapy
 urn:newsml:reuters.com:*:nGNX6PH8gV
** XBIT recently developed screening technology that identifies
blood donors that have COVID-19 immunity, in partnership with a
blood donor organisation 
** XBIT believes that individuals with evidence of a vigorous
antibody response against COVID-19 in the absence of a history
of serious illness are ideal for identifying antibodies
** Co says it has begun the discovery process
** Stock has fallen ~15% YTD 

 (Reporting by Dania Nadeem in Bengaluru)
 ((dania.nadeem@thomsonreuters.com))